Treatment of Atrial Fibrillation With Antiarrhythmic Drugs or Radiofrequency Ablation: Two Systematic Literature Reviews and Meta-Analyses

By H. Calkins, Matthew R. Reynolds, P. Spector, Manu Sondhi, Yingxin Xu, Amber Martin, C. Williams, I. Sledge. Circulation: Arrhythmia and Electrophysiology, 2009

800 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine

View Paper: https://www.semanticscholar.org/paper/3607d14803d1122e727eb58b0d7b559c548e0fa9

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

Citations in the corpus

Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front (STOP AF) pivotal trial. (2013, result): “9% treatment success rate was higher than that predicted by a recent meta-analyses of randomized and observational studies (17) of standard RF ablation, suggesting the potential for simplification of the ablation process by eliminating the need for point-to-point manipulation of the catheter.”
Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). (2010, result): “and catheter ablation as first-line therapy in patients with symptomatic paroxysmal AF are scarce,(134) but separate analyses of the efficacy of antiarrhythmic drugs and of LA catheter ablation in AF imply greater benefit from ablation.(131) However, considering”
2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. (2014, neutral): “AF catheter ablation is useful for symptomatic paroxysmal AF refractory or intolerant to at least 1 class I or III antiarrhythmic medication when a rhythm control strategy is desired (154-160).”
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. (2016, neutral): “Most patients require more than one procedure to achieve symptom control.(713,726,728) In general, better rhythm outcome and lower procedure-related complications can be expected in younger patients with a short history of AF and frequent, short AF episodes in the absence of significant structural h”
2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation (2017, background): “The many trials comparing AF ablation with AADs for second-line rhythm control have been evaluated in a number of meta-analyses and technology assessments.(262,1031,1032) Pooling of results across trials indicates that AF ablation is clearly superior to AAD therapy for the maintenance of sinus rhyth”